Overseas revenue

Recent Articles

RELATED ARTICLES

  1. The latest draft of a U.S. biosecurity law would give drug companies until 2032 to cut their ties with Chinese contract suppliers, allowing WuXi companies time to focus on Europe instead.
    U.S. rethinks timing of biotech crackdown, easing pressure on WuXi family
    2269.HK 2359.HK 2268.HK
  2. Potential U.S. targeting casts shadow over WuXi AppTec family
    2359.HK 603259.SHG
  3. WuXi AppTec posts lower profits but avoids more share price pain  
    2359.HK 603259.SHG
  4. WuXi AppTec mulls gene unit sale to soften U.S. legal blow
    2359.HK 603259.SHG
  5. CHINA BULLETIN: Manufacturing Déjà Vu
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva